Argonaute2 (Ago2) is an established component of the microRNA-induced silencing complex. Similar to miR-375 loss-of-function studies, inhibition of Ago2 in the pancreatic -cell resulted in enhanced insulin release underlining the relationship between these two genes. Moreover, as the most abundant microRNA in pancreatic endocrine cells, miR-375 was also observed to be enriched in Ago2-associated complexes. Both Ago2 and miR-375 regulate the pancreatic -cell secretome, and by using quantitative mass spectrometry, we identified the enhanced release of a set of proteins or secretion "signatures " in response to a glucose stimulus using the murine -cell line MIN6. In addition, the loss of Ago2 resulted in the increased expression of miR-375 target genes, including gephyrin and ywhaz. The four mammalian Argonaute proteins mediate the microRNA pathway in mammalian cells by recruiting the noncoding RNAs to interact with their target mRNAs (1, 2). Whereas 60% of all mRNAs are predicted to be targets of microRNAs, the function of individual Argonaute proteins in this process is largely uncharacterized (3). Interestingly, only total loss of Argonaute2 (Ago2) expression results in embryonic lethality, although genetic deletion of the other family members does not appear to influence embryonic development in the mouse (4). In addition, Ago2 has been shown to constitute a rate-limiting determinant in RNAi efficacy (5). Although the role of the Argonaute family has not been elucidated in the pancreatic -cell, miR-375, the most abundant microRNA in the pancreatic islet, has been shown to regulate both the growth and function of the -cell (6, 7).Within the endocrine pancreas, several cell types (␣, , ␦, and pancreatic polypeptide) release hormones into the circulation to regulate a broad spectrum of physiologic pathways (8). The pancreatic -cell is the only source of insulin in the body and continuously responds to both glucose and electrical stimuli by releasing proteins into the blood (9). Processing of the proinsulin molecule occurs during assembly of the secretory granule when insulin is crystallized leading to the formation of mature dense-core granules (8). Several reports suggest the number of proteins in the insulin secretory granules to range between 50 and 150 as identified using mass spectrometry (10 -12). The dense granules are transported and stored to comprise a readily releasable pool and, upon stimulation, fuse to the plasma membrane and constitute first-phase insulin release (13).In this study, we address the regulatory role of Ago2 in the secretion pathway of the pancreatic -cell. Proteins exocytosed from the murine insulinoma cell line MIN6 in response to glucose into the extracellular environment were quantified using a stable isotope labeling with amino acids in cell culture (SILAC) 1 -based approach (14,15). Comparison of the proteins detected in the supernatant after induction by high glucose with those inhibited after loss of glucokinase expression includes a set of secreted -cell proteins or se...